Diacetolol
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
N-[3-acetyl-4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status |
|
| Pharmacokinetic data | |
| Biological half-life | 8-13 hours |
| Identifiers | |
| CAS Number | 22568-64-5 |
| ATC code | none |
| PubChem | CID 50894 |
| ChemSpider |
46139 |
| UNII |
4ER0CZ5G7C |
| ChEMBL | CHEMBL2106189 |
| Chemical data | |
| Formula | C16H24N2O4 |
| Molar mass | 308.37 g/mol |
| |
| |
| (verify) | |
Diacetolol is the primary metabolite of acebutolol. It is an beta blocker and anti-arrhythmic agent.[1]
References
- ↑ Berkeley Basil, Roy Jordan (7 May 1982). "Pharmacological properties of diacetolol (M&B 16,942), a major metabolite of acebutolol". European Journal of Pharmacology 80: 47–56. doi:10.1016/0014-2999(82)90176-5.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
